GLP1R and Insulin resistance: As increased BMI impairs GLP-1 secretion and aggravates insulin resistance, the supraphysiological infusions of GLP-1 may act as a positive feedback signal in obese patients to improve insulin sensitivity and reduce chronic obesity.